DOI: 10.1128/AAC.00777-19
Article Information
PubMed
Published By
History
- Received April 10, 2019
- Returned for modification April 28, 2019
- Accepted July 16, 2019
- Published online September 23, 2019.
Copyright & Usage
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (July 22, 2019).
- You are viewing the most recent version of this article.
Author Information
- Michaelle Chojnackia,
- Alesa Philbricka,
- Tyler Scherzia,
- Nicole Pecorab,
- Paul M. Dunmana and
- Rachel A. F. Wozniakc
- aDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
- bDepartment of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
- cDepartment of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
- Address correspondence to Rachel A. F. Wozniak, rachel_wozniak{at}urmc.rochester.edu.
Citation Chojnacki M, Philbrick A, Scherzi T, Pecora N, Dunman PM, Wozniak RAF. 2019. A novel, broad-spectrum antimicrobial combination for the treatment of Pseudomonas aeruginosa corneal infections. Antimicrob Agents Chemother 63:e00777-19. https://doi.org/10.1128/AAC.00777-19.
